The MCAS (Mast Cell Activation) Strategy

Read Time: 25 Minutes
Clinical Focus: Histamine Intolerance, DAO Enzymes, Mast Cell Stabilization

You react to "everything." You have already cut out avocados, spinach, and leftovers because you noticed they make you feel terrible, even before you knew why. You are sensitive to perfumes and cleaning products. You flush red when you drink wine. You have IBS that flares at random. You have been told it is anxiety, or you are too sensitive, or you should "just eat normally."

This is likely Mast Cell Activation Syndrome (MCAS). Your mast cells, the immune sentries embedded in every tissue, are hyper-responsive. They are degranulating at low thresholds, dumping histamine, tryptase, prostaglandins, and cytokines into your blood. The MCAS Strategy is the playbook for stabilizing the system, expanding your dietary range, and getting your life back.

What is the bucket theory of histamine load?

It is not a "crash." It is an overflow. Imagine a bucket with a hole at the top. Water comes in from many sources. As long as the inflow stays below the brim, you feel fine. When the inflow exceeds capacity, the bucket overflows and you have a reaction.

Inputs to the bucket:

• Histamine in food: Aged cheeses, cured meats, fermented foods, leftovers, alcohol, certain fish (tuna, mackerel).
• Heat: Hot showers, summer days, exercise.
• Stress: Acute or chronic; cortisol triggers mast cells.
• Infection: Active or recent viral exposure (COVID, EBV, herpesviruses).
• Hormonal shifts: Estrogen activates mast cells; many patients see flares mid-cycle and in perimenopause.
• Toxins: Mold, off-gassing chemicals, certain medications.

Outflows from the bucket:

• DAO enzyme in the gut, which breaks down dietary histamine.
• HNMT enzyme intracellularly, which clears histamine systemically.
• Sleep, recovery, and parasympathetic activity.

The strategy is to lower the inflow, raise the outflow, and stabilize the mast cells themselves.

What is the diagnostic workup for MCAS?

MCAS diagnosis is challenging because mediators are released in bursts and clear quickly. Standard testing is often normal in patients with clear clinical disease.

Standard Mediators

• Serum tryptase: Should be drawn within 1 to 4 hours of a flare for highest yield. Baseline tryptase elevated above 11.4 ng/mL is consistent with mastocytosis. A rise of 20 percent plus 2 ng/mL between baseline and flare is supportive of MCAS.
• Plasma histamine: Highly variable. Useful in burst reactions but easily missed.
• 24 hour urine: N-methylhistamine, prostaglandin D2 metabolites, leukotriene E4. Captures longer windows than serum.
• Chromogranin A: Sometimes elevated, but non-specific.

Supportive Testing

• Diagnostic trial of MCAS treatment: Improvement on H1/H2 blockers plus mast cell stabilizers is supportive evidence.
• DAO enzyme level (serum): Low DAO supports histamine intolerance as a contributor.
• Allergy panel (IgE): To distinguish from true IgE mediated allergy.
• Comorbid screening: hEDS (joint hypermobility), POTS (autonomic dysfunction), Lyme and co-infections, mold exposure history.

Comorbidity Triad

A meaningful share of MCAS patients have one or both of:

• Hypermobile Ehlers-Danlos Syndrome (hEDS)
• Postural Orthostatic Tachycardia Syndrome (POTS)

The triad of MCAS, hEDS, and POTS is common enough that we screen for all three when one is suspected.

{{NEWSLETTER}}

What is the strategic roadmap for MCAS treatment?

The goal is not lifelong restriction. The goal is to lower the bucket level so you have room for life.

Phase 1: Lowering the Inflow (Diet and Environment)

A short term low histamine diet calms the system enough to start treatment. We use it as a tool, not a permanent prescription.

• Avoid for 4 to 6 weeks: aged cheeses, cured meats, fermented foods, leftovers (refrigerated more than 24 hours), alcohol (especially wine), tomato, spinach, eggplant, avocado, banana, citrus, chocolate, vinegar.
• Favor fresh proteins (chicken, lamb, turkey, freshly caught fish), fresh produce (zucchini, cucumber, lettuce, apple, pear, blueberry), gluten-free grains, fresh herbs.
• Cook fresh and freeze immediately: Histamine accumulates as food sits.
• Reduce environmental triggers: Fragrances, scented candles, harsh cleaning products, mold exposure.

Phase 2: Stabilizing the Mast Cells (The Tools)

This is where most patients see real change.

Antihistamines (foundation)

• H1 blockers: Cetirizine 10 to 20 mg morning, fexofenadine 180 mg morning, or hydroxyzine 25 to 50 mg at night for breakthrough symptoms.
• H2 blockers: Famotidine 20 to 40 mg twice daily.

Mast Cell Stabilizers

• Cromolyn sodium (oral): 100 to 200 mg four times daily, taken 30 minutes before meals. Coats mast cells in the GI tract. Often makes the difference for patients with prominent GI symptoms.
• Ketotifen: 1 to 4 mg at night. H1 blocker plus mast cell stabilizer. Compounded in the US.
• Quercetin: 500 to 1,000 mg twice daily. Plant flavonoid with mast cell stabilizing effect.
• Luteolin: 100 to 200 mg twice daily, often combined with quercetin.

Histamine Clearance Support

• DAO enzyme supplements (Diamine Oxidase): Taken 15 minutes before meals. Helps break down histamine in food. Allows wider dietary range.
• Vitamin C: 500 to 1,000 mg twice daily. Cofactor for DAO and natural antihistamine.
• Vitamin B6 (P5P form): 25 to 50 mg daily. Cofactor for DAO.

Other Supportive Medications

• Low Dose Naltrexone (LDN): 1.5 to 4.5 mg at bedtime. Modulates immune activation, often helpful for the inflammatory and pain components.
• Aspirin (low dose): 81 mg daily for prostaglandin component, in select patients without contraindication.
• Singulair (montelukast): 10 mg daily for leukotriene component, especially with respiratory symptoms.

Phase 3: Treating the Drivers

Mast cell activation rarely happens in a vacuum. We look for and treat the underlying drivers.

• Chronic infection: Lyme, Bartonella, viral persistence (Long COVID, EBV reactivation).
• Mold exposure: Water damaged building, urine mycotoxin testing when indicated.
• Hormonal optimization: Estrogen/progesterone balance, thyroid optimization.
• Gut health: Treat SIBO, restore microbial diversity, address intestinal permeability.

Phase 4: Reintroduction and Expansion

Once symptoms are stable for 2 to 3 months, we reintroduce foods one at a time, watching for reactions. Many patients can return to a much wider diet than they had at the start.

Actionable Steps for Suspected MCAS

1. Start the OTC stabilization stack: cetirizine 10 mg morning, famotidine 20 mg twice daily, quercetin 500 mg twice daily, vitamin C 500 mg twice daily.
2. Try a 4 week low histamine trial if reactions are food triggered.
3. Reduce environmental triggers: fragrances, candles, harsh cleaners, mold exposure.
4. Get baseline labs: serum tryptase, 24 hour urine N-methylhistamine, full thyroid, ferritin, vitamin D.
5. Find a physician who treats MCAS as a real biomedical condition, not anxiety.

Common Questions

Is MCAS a recognized diagnosis?

Yes. MCAS has formal diagnostic criteria published by international consensus groups, and ICD-10 codes for billing. The condition is recognized by allergy and immunology professional societies, although awareness varies among general clinicians. Anyone telling you MCAS is not real is not current with the literature.

How is MCAS different from allergies?

True IgE mediated allergies cause reactions to specific proteins (peanut, shellfish, latex) within 30 minutes, mediated by IgE antibodies. MCAS causes reactions to a wide range of triggers (foods, smells, stress, heat, hormones), often delayed, and is mediated by mast cell over-activation rather than specific allergen recognition. Many MCAS patients have negative IgE testing for the foods they react to.

What is histamine intolerance versus MCAS?

Histamine intolerance is a narrower concept: the body cannot break down dietary histamine fast enough, often due to low DAO enzyme activity. MCAS is a broader concept: the mast cells themselves are over-active and release multiple mediators (histamine, tryptase, prostaglandins, leukotrienes). Histamine intolerance is essentially a subset or contributing factor in many MCAS presentations.

Will I have to follow a low histamine diet forever?

No. A low histamine diet is a short term tool to calm the system, typically 4 to 8 weeks. Once mast cells are stabilized with medication and supplements, most patients can reintroduce many foods. The goal is dietary freedom, not permanent restriction.

What is DAO enzyme and how does it help?

Diamine oxidase (DAO) is the enzyme in the gut that breaks down histamine in food. Many MCAS patients have low DAO activity. Taking a DAO supplement before meals provides additional enzyme to clear dietary histamine. The result is being able to eat a broader range of foods without reaction. Brands include Histamine Block, Daosin, and others.

Can I take Zyrtec and Pepcid every day?

Yes. Cetirizine (Zyrtec) and famotidine (Pepcid) are safe for daily long term use in most adults. They are non-sedating in the case of cetirizine, and famotidine has an excellent safety profile. Talk to your physician if you have specific medical conditions or are pregnant.

What is cromolyn sodium and is it a steroid?

Cromolyn sodium is a mast cell stabilizer. It is not a steroid. It is taken orally as a liquid (Gastrocrom) or compounded capsules, four times daily, 30 minutes before meals. It coats mast cells in the GI tract and prevents degranulation. It is particularly useful for patients with prominent GI symptoms. It requires a prescription.

Can MCAS cause anxiety and panic?

Yes. Histamine and other mast cell mediators directly activate the sympathetic nervous system, which can produce anxiety, panic, racing heart, and a sense of impending doom. Many MCAS patients have been told they have anxiety disorders when the underlying driver was mast cell activation. Treating the mast cells often resolves the "anxiety" entirely.

Why are women more affected than men?

Estrogen activates mast cells, and progesterone has stabilizing effects in some patients. Many women see flares mid-cycle, in pregnancy, and especially in perimenopause as estrogen levels become erratic. Men can develop MCAS, but the prevalence is meaningfully higher in women.

Is MCAS related to Long COVID?

There is substantial overlap. Many Long COVID patients develop new mast cell activation that did not exist before. Treating the mast cell component is often a key part of Long COVID recovery. The mechanisms appear related: viral debris, persistent inflammation, and immune dysregulation.

Can children have MCAS?

Yes, although we do not see pediatric patients. For children with suspected MCAS, we refer to allergy and immunology specialists with pediatric expertise.

What about the MCAS, POTS, and hEDS triad?

A meaningful share of MCAS patients have one or both of POTS (Postural Orthostatic Tachycardia Syndrome) and hEDS (hypermobile Ehlers-Danlos Syndrome). The three conditions cluster, possibly because of shared genetic and connective tissue factors. We screen for all three when one is suspected, and we treat them in parallel.

Deep Questions

How does Fishtown Medicine personalize the MCAS strategy?

We map the dominant mediator pattern first. A patient with prominent GI symptoms and food reactions needs cromolyn and DAO support. A patient with prominent flushing and respiratory symptoms needs aspirin and montelukast added. A patient with prominent neuropsychiatric symptoms and pain needs LDN and possibly ketotifen. The personalization is in the layering and sequence.

What is the role of testing for the MCAS, POTS, hEDS triad?

We screen for hEDS with the Beighton score (joint hypermobility) and the 5 part questionnaire. We screen for POTS with a 10 minute lean test or formal tilt table. We screen for MCAS with the workup described above. When all three are present, treatment is parallel: salt and volume for POTS, mast cell stabilization for MCAS, and physical therapy for hEDS, all of which interact.

How do you handle MCAS in pregnancy?

Pregnancy is complex because hormones drive flares but treatment options are restricted. We continue safe medications (cetirizine and loratadine are pregnancy compatible, famotidine is generally safe), avoid medications without good safety data, and rely more heavily on dietary management, sleep, and stress reduction. We coordinate closely with maternal-fetal medicine for high risk patients.

What is the role of low dose naltrexone in MCAS?

LDN (1.5 to 4.5 mg at bedtime) modulates immune activation, including microglial mast cells in the central nervous system. We use it commonly for the inflammatory and pain components of MCAS, particularly in patients with prominent fibromyalgia overlap or chronic regional pain. It is generic, inexpensive, and well tolerated, but requires compounding pharmacy access.

How do you handle the mold and biotoxin overlap?

Many MCAS patients have a history of significant mold exposure (water damaged building, flood damage, hidden leaks). The mycotoxins themselves trigger mast cell activation and create a chronic inflammatory state. We screen with a thorough exposure history and urine mycotoxin testing when indicated. Treatment includes environmental remediation (removing the patient from the exposure or remediating the building), binders (cholestyramine, activated charcoal, bentonite clay), and detoxification support. Treating MCAS without addressing ongoing mold exposure is difficult.

What about chronic infection drivers?

Chronic Lyme, Bartonella, Babesia, EBV reactivation, and other persistent infections can drive mast cell activation. We screen for tick borne infection in patients with suggestive history and treat appropriately. We screen for EBV reactivation with EBV PCR in patients with prominent fatigue and lymph node prominence. Treating the underlying infection often reduces the MCAS burden.

How does estrogen affect MCAS and what can be done?

Estrogen activates mast cells. Estrogen dominance (relative excess of estrogen versus progesterone) often worsens MCAS. We assess hormonal balance with day 21 progesterone, estradiol, and a careful symptom history. We use cyclical or continuous bio-identical progesterone (oral micronized) when indicated, and we manage the estrogen side with diet (cruciferous vegetables, DIM), liver support, and gut microbial modulation.

What is the role of diamine oxidase (DAO) testing?

Serum DAO can be measured. Low values support histamine intolerance as a contributor. We use the test selectively because DAO supplementation often helps regardless of the test result, and the test has variability. The clinical trial of DAO supplementation is often more useful than the lab test.

How do you handle anaphylaxis risk in MCAS?

Patients with severe MCAS can have anaphylactic reactions to seemingly minor triggers. We prescribe an EpiPen for any patient with a history of systemic reaction, train them and their family in its use, and document the diagnosis prominently in the chart. We also provide a written emergency action plan with the medications and doses to use during a flare.

What about IV interventions for severe MCAS?

For severe refractory MCAS, IV interventions can include IV antihistamines, IV cromolyn, IV vitamin C, and in select cases IV solumedrol pulses. These are delivered in coordination with allergy and immunology specialists. We do not run IV infusions in primary care.

What is the prognosis for MCAS?

With appropriate treatment, most MCAS patients achieve substantial functional improvement. Many return to a near-normal diet and reduce medication burden over time. A subset have persistent disease that requires lifelong management. Prognosis is better when underlying drivers (infection, mold, hormonal imbalance) are identified and addressed.

What is the Warm Invitation Call?

It is a 20 minute video conversation, free, with no commitment. You tell us your story, what testing has been done, and what is and is not working. We tell you whether the model fits. If we are not a good fit for your specific complexity, we will say so and often help you find a better option.

Scientific References

1. Afrin, L. B., et al. (2020). Diagnosis of mast cell activation syndrome: a global consensus-2. Diagnosis, 8(2), 137-152.
2. Molderings, G. J., et al. (2011). Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology & Oncology, 4, 10.
3. Maintz, L., & Novak, N. (2007). Histamine and histamine intolerance. American Journal of Clinical Nutrition, 85(5), 1185-1196.
4. Theoharides, T. C., et al. (2015). Mast cells, mastocytosis, and related disorders. New England Journal of Medicine, 373(2), 163-172.
5. Weinstock, L. B., et al. (2021). Mast Cell Activation Symptoms Are Prevalent in Long-COVID. International Journal of Infectious Diseases, 112, 217-226.

---

Conclusion

You have been managing this minefield alone, cutting out more and more foods. We help you reverse the process. We stabilize the system so you can expand your world again.

Book Your Diagnostic. Let's empty the bucket.

---

Medical Disclaimer: This resource provides Clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right supplement protocol must be matched to your unique lab work, physiology, and performance goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.